ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug GEN1057 trial ends early
Disease control TerminatedThis early-stage trial tested a new antibody drug called GEN1057 in 23 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control
Last updated May 17, 2026 05:24 UTC
-
Liver Function's impact on cancer drug tazemetostat under microscope
Knowledge-focused TerminatedThis study looked at how the drug tazemetostat is processed in the body of people with advanced cancer who also have moderate or severe liver problems. It compared their blood drug levels to those with normal liver function. The goal was to understand safety and dosing, but the s…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:27 UTC